 |
|
Connected As: <Anonymous> Contact: srcosmos@aegean.gr |
|
|
|
Connected As: <Anonymous> Contact: srcosmos@aegean.gr |
| Times Cited | Cited Author | Cited work | SRCosmos Link | ||||||||
| Citations by articles in Journals | |||||||||||
| 1 | LUO W... | Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, ET AL. Phospholamban gene dosage effects in the mammalian heart. Circ Res 1996, 78:839---847. | Cited by... | ||||||||
| 1 | LUO W... | Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, ET AL. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of betaagonist stimulation. Circ Res 1994, 75:401---409. | Cited by... | ||||||||
| 1 | ...Luo W | Wolska BM, Stojanovic MO, Luo W, Kranias EG, Solaro RJ, Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca 2+ . Am J Physiol 1996, 271(1 Pt 1):C391---C397. | Cited by... | ||||||||
| 1 | ...Luo W | Kiss E, Edesi I, Sato Y, Luo W, Liggett SB, Kranias EG, beta-adrenergic regulation of cAMP and protein phosphorylation in phospholambanknockout mouse hearts. Am J Physiol 1997, 272(2 Pt 2):H785---H790. | Cited by... | ||||||||
| 1 | LUO W... | Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, Kranias EG, Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J Biol Chem 1998, 273:4734---4739. | Cited by... | ||||||||
| Citations by articles in Conferences | |||||||||||
| 1 | LUO W... | Luo W, Wang F, 2003, Measures of spatial accessibility to health care in a GIS environment: synthesis and a case study in the Chicago region, Environment and Planning B, 30, pp. 865 – 884. | Cited by... | ||||||||
